{"disease":{"id":"uremic-pruritus","name":"uremic pruritus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03636269","title":"CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":473,"lead_sponsor_name":"Cara Therapeutics, Inc.","has_results":true},{"nct_id":"NCT03422653","title":"A Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":378,"lead_sponsor_name":"Cara Therapeutics, Inc.","has_results":true},{"nct_id":"NCT03281538","title":"Extension Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":288,"lead_sponsor_name":"Cara Therapeutics, Inc.","has_results":true},{"nct_id":"NCT03218501","title":"A Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":269,"lead_sponsor_name":"Sanwa Kagaku Kenkyusho Co., Ltd.","has_results":false},{"nct_id":"NCT05885737","title":"Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":260,"lead_sponsor_name":"Vifor Fresenius Medical Care Renal Pharma","has_results":true},{"nct_id":"NCT03802617","title":"A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":247,"lead_sponsor_name":"Kissei Pharmaceutical Co., Ltd.","has_results":true},{"nct_id":"NCT03998163","title":"CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":222,"lead_sponsor_name":"Cara Therapeutics, Inc.","has_results":true},{"nct_id":"NCT06446310","title":"Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":194,"lead_sponsor_name":"Qilu Pharmaceutical (Hainan) Co., Ltd.","has_results":false},{"nct_id":"NCT04711603","title":"A Phase III Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":178,"lead_sponsor_name":"Kissei Pharmaceutical Co., Ltd.","has_results":true},{"nct_id":"NCT04728984","title":"A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":135,"lead_sponsor_name":"Shenyang Sunshine Pharmaceutical Co., LTD.","has_results":false},{"nct_id":"NCT04470154","title":"A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of HSK21542 Injection in Subjects Undergoing Hemodialysis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":131,"lead_sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT04639674","title":"AST-120 in Hemodialysis Patients With Uremic Pruritus","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Conmed Pharmaceutical & Bio-Medical Corporation","has_results":false},{"nct_id":"NCT05466045","title":"Using of Extra Virgin Olive Oil in Hemodialysis Patients to Improve Pruritus and Sleep Disorders","phase":"NA","overall_status":"UNKNOWN","enrollment_count":86,"lead_sponsor_name":"National Taipei University of Nursing and Health Sciences","has_results":false},{"nct_id":"NCT03576235","title":"Safety and Efficacy of PG102P for Uremic Pruritus in HD Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Seoul National University Boramae Hospital","has_results":false},{"nct_id":"NCT04650750","title":"The Treatment Effect of Chinese Medicine Formula on Uremic Pruritus","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT06466421","title":"Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT06159686","title":"The Efficacy of Hemp-containing Cream Versus Placebo in the Treatment of Uremic Pruritus","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Thammasat University Hospital","has_results":false},{"nct_id":"NCT06190132","title":"The Effect of Omega-3 Fatty Acids Versus Gabapentin in Uremic Pruritus in Hemodialysis Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT05575193","title":"Acupressure on Uremic Pruritus and Sleep Quality Among Patients Receiving Hemodialysis","phase":"NA","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"National Taipei University of Nursing and Health Sciences","has_results":false},{"nct_id":"NCT05525234","title":"A Study of Thalidomide in the Treatment of Refractory Uremic Pruritus","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT04393675","title":"Study to Investigate the Safety of LT5001 Drug Product for Uremic Pruritus in Hemodialysis Patients","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":18,"lead_sponsor_name":"Lumosa Therapeutics Co., Ltd.","has_results":true},{"nct_id":"NCT03758079","title":"Comparison of Gabapentin With Doxepin in the Management of Uremic Pruritus","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"University of Balamand","has_results":false},{"nct_id":"NCT05031546","title":"Intermediate-Size Patient Population Expanded Access Program for Intravenous Difelikefalin","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Cara Therapeutics, Inc.","has_results":false}],"total":23},"guidelines":[],"source":"Drug Landscape verified database"}